Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory spine RS3 residue of protein kinases: a lipophilic bystander or a decisive element in the small-molecule kinase inhibitor binding? | Biochem Soc Trans | 2022 | 35226061 | PubTator, text mining | PubMed |
| Spinal cord injury reprograms muscle fibroadipogenic progenitors to form heterotopic bones within muscles. | Bone Res | 2022 | 35217633 | PubTator, text mining | PubMed |
| Hypoxia Is a Dominant Remodeler of the Effector T Cell Surface Proteome Relative to Activation and Regulatory T Cell Suppression. | Mol Cell Proteomics | 2022 | 35217172 | PubTator, text mining | PubMed |
| JAK2 in Myeloproliferative Neoplasms: Still a Protagonist. | Pharmaceuticals (Basel) | 2022 | 35215273 | PubTator, text mining | PubMed |
| Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms. | Cancers (Basel) | 2022 | 35205715 | PubTator, text mining | PubMed |
| Functional Validation of Osteoporosis Genetic Findings Using Small Fish Models. | Genes (Basel) | 2022 | 35205324 | PubTator, text mining | PubMed |
| Preeclampsia, Natural History, Genes, and miRNAs Associated with the Syndrome. | J Pregnancy | 2022 | 35198246 | PubTator, text mining | PubMed |
| Bone morphogenetic protein receptor inhibitors suppress the growth of glioblastoma cells. | Mol Cell Biochem | 2022 | 35192123 | PubTator, text mining | PubMed |
| Updates on Clinical Trials for Myelofibrosis: Highlights From SOHO 2021. | J Adv Pract Oncol | 2022 | 35186404 | PubTator, text mining | PubMed |
| Inhibition of BMP signaling with LDN 193189 can influence bone marrow stromal cell fate but does not prevent hypertrophy during chondrogenesis. | Stem Cell Reports | 2022 | 35180395 | PubTator, text mining | PubMed |
| Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways. | BMC Biol | 2022 | 35177083 | PubTator, text mining | PubMed |
| Fibrin-based factor delivery for therapeutic angiogenesis: friend or foe? | Cell Tissue Res | 2022 | 35175429 | PubTator, text mining | PubMed |
| The Induced Pluripotent Stem Cells in Articular Cartilage Regeneration and Disease Modelling: Are We Ready for Their Clinical Use? | Cells | 2022 | 35159338 | PubTator, text mining | PubMed |
| A Single-Cell Omics Network Model of Cell Crosstalk during the Formation of Primordial Follicles. | Cells | 2022 | 35159142 | PubTator, text mining | PubMed |
| Heterotopic Ossification: Clinical Features, Basic Researches, and Mechanical Stimulations. | Front Cell Dev Biol | 2022 | 35145964 | PubTator, text mining | PubMed |
| Roles of Wnt Signaling Pathway and ROR2 Receptor in Embryonic Development: An Update Review Article. | Epigenet Insights | 2022 | 35128307 | PubTator, text mining | PubMed |
| Tracing the cis-regulatory changes underlying the endometrial control of placental invasion. | Proc Natl Acad Sci U S A | 2022 | 35110402 | PubTator, text mining | PubMed |
| Allele-Selective LNA Gapmers for the Treatment of Fibrodysplasia Ossificans Progressiva Knock Down the Pathogenic ACVR1R206H Transcript and Inhibit Osteogenic Differentiation. | Nucleic Acid Ther | 2022 | 35085461 | PubTator, text mining | PubMed |
| Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways. | Cells | 2022 | 35053339 | PubTator, text mining | PubMed |
| Editorial of Special Issue "Fibrodysplasia Ossificans Progressiva: Studies on Disease Mechanism towards Novel Therapeutic Approaches". | Biomedicines | 2022 | 35052819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=36